Vol. 7, Issue 1, Part A (2025)

Transurethral resection of the prostate (TURP) is an endoscopic procedure used to remove prostatic tissue. It is recommended for patients with moderate (8-19) to severe (20-35) lower urinary tract symptoms (LUTS) that do not respond to medical treatment, those with refractory urinary retention following at least one unsuccessful catheter removal attempt and cases of chronic urinary retention causing hydronephrosis or renal impairment due to back pressure changes. Additionally, TURP is indicated for complications of benign prostatic hyperplasia, such as recurrent urinary tract infections, persistent gross hematuria, bladder diverticula and bladder stones. This study aims to analyze TURP procedures performed at the Libyan Swiss Center, Masara Clinic, Ghout Shaal Hospital, Libya, involving 260 cases during the period from January 2019 to December 2024.
The age of the patients varies from < 50 is 13.46%, 51 to 70 is 69.23% and greater than 70 is 17.30%. Duration of BPH in years lies between < 5 is 27.30%, 6 to 10 is 51.15% and greater than 80 is 21.53%. The volume of prostate (ml) < 40 is 39.23%, 40 to 80 is 32.30%, > 80 is 28.46%. Bladder stone (cm) < 1 is 34.23%, 2 to 3 is 35.76% and > 4 is 30%. Hypertension in patients is 16.15%, Diabetes in patients is 12.69% and Coronary heart disease is 6.92%. the operative time taken nearly average 60 minutes to 90 minutes, the time taken less than 60 minutes is 11.92%, 60 to 90 minutes is 70% and greater than 90 is 18.07%. The preoperative hemoglobin (g/dL) less than 6 is 9.23%, 6 to 10 is 73.07% and greater than 10 is 17.69%. The massive blood loss occurs in patients about 13.46%, the postoperative secondary bleeding occurred in 6.92% patients; blood transfusion occurred in patients about 8.46%, the bladder injury is 3.84%, the urinary tract irritation also occurred about 2.69%. The bladder spasm is 3.07% and urinary tract infection is 4.61%. The clot retention is 2.30% respectively.